Be part of the knowledge.™

Oncology and Hematology

838

LikeLikedUnlike

1-15 of 271

Addressing Unmet Needs in Metastatic Uveal Melanoma
CME/CE
Addressing Unmet Needs in Metastatic Uveal Melanoma
- Marlana Orloff, MD
  Peer
- Gregory Daniels, MD, PhD
  Peer
- Jesse Keller, MD
  Peer
1.00 credits
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
CME/CE
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
- Ryan D. Cassaday, MD
  Peer
- Daniel J. DeAngelo, MD, PhD
  Peer
1.00 credits
MinuteCE®
Beyond the Joint: Cross-Specialty Solutions for Advancing TGCT Patient Care
- A.J. Gelderblom, MD, PhD
  Peer
- Michiel van de Sande, MD, PhD
  Peer
- Chelsea Cole, MD
  Peer
1.00 credits 10 episodes
The Tumor That’s Not So Tiny: Understanding the Impact of TGCT
MinuteCE®
The Tumor That’s Not So Tiny: Understanding the Impact of TGCT
- A.J. Gelderblom, MD, PhD
  Peer
1.00 program credits
Beyond the Scalpel: When TGCT Surgery Isn’t the Solution
MinuteCE®
Beyond the Scalpel: When TGCT Surgery Isn’t the Solution
- Michiel van de Sande, MD, PhD
  Peer
1.00 program credits
Unlocking the CSF1R Code: Targeted Pathways and Tailored Choices
MinuteCE®
Unlocking the CSF1R Code: Targeted Pathways and Tailored Choices
- A.J. Gelderblom, MD, PhD
  Peer
1.00 program credits
advertisement
Clinical Evidence in Focus: Interpreting Data on Systemic Therapy Targeting CSF1R
MinuteCE®
Clinical Evidence in Focus: Interpreting Data on Systemic Therapy Targeting CSF1R
- A.J. Gelderblom, MD, PhD
  Peer
1.00 program credits
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
MinuteCE®
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
- A.J. Gelderblom, MD, PhD
  Peer
- Michiel van de Sande, MD, PhD
  Peer
1.00 program credits
Emerging Evidence in Focus: Interpreting Data on Next-Generation CSF1R TKIs
MinuteCE®
Emerging Evidence in Focus: Interpreting Data on Next-Generation CSF1R TKIs
- A.J. Gelderblom, MD, PhD
  Peer
1.00 program credits
Applying the Evidence: TGCT Treatment Insights for Sports Medicine Physicians
MinuteCE®
Applying the Evidence: TGCT Treatment Insights for Sports Medicine Physicians
- A.J. Gelderblom, MD, PhD
  Peer
- Chelsea Cole, MD
  Peer
1.00 program credits
The Safety Equation: Managing Adverse Events Associated With CSF1R Inhibitors in TGCT
MinuteCE®
The Safety Equation: Managing Adverse Events Associated With CSF1R Inhibitors in TGCT
- A.J. Gelderblom, MD, PhD
  Peer
1.00 program credits
Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
MinuteCE®
Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
- A.J. Gelderblom, MD, PhD
  Peer
1.00 program credits
advertisement
All Sides of the Joint: Integrated TGCT Care Across Specialties
MinuteCE®
All Sides of the Joint: Integrated TGCT Care Across Specialties
- A.J. Gelderblom, MD, PhD
  Peer
- Michiel van de Sande, MD, PhD
  Peer
- Chelsea Cole, MD
  Peer
1.00 program credits
MinuteCE®
From Data to Debate: Global Perspectives on HR+/HER2- mBC Care
- Komal Jhaveri, MD, FACP
  Peer
- Giuseppe Curigliano, MD, PhD
  Peer
- Cynthia Villarreal-Garza, MD, DSc
  Peer
- Hiraji Iwata, MD, PhD
  Peer
1.00 credits 10 episodes
Unmet Needs in Endocrine Therapy: Rethinking the HR+/HER2- mBC Treatment Roadmap
MinuteCE®
Unmet Needs in Endocrine Therapy: Rethinking the HR+/HER2- mBC Treatment Roadmap
- Komal Jhaveri, MD, FACP
  Peer
1.00 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended